— Know what they know.
Not Investment Advice

AEMD NASDAQ

Aethlon Medical, Inc.
1W: +2.7% 1M: +254.4% 3M: +63.3% YTD: -54.3% 1Y: -82.3% 3Y: -99.3% 5Y: -100.0%
$6.45
-0.18 (-2.71%)
 
Weekly Expected Move ±188.1%
$-18 $-6 $6 $19 $31
NASDAQ · Healthcare · Medical - Devices · Tech Score Buy · Power 56 · $3.4M mcap · 470274 float · 174.45% daily turnover · Short 54% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
41.3 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -2931.8%  ·  5Y Avg: -1298.0%
Cost Advantage
56
Intangibles
58
Switching Cost
18
Network Effect
39
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AEMD shows a Weak competitive edge (41.3/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. Negative ROIC of -2931.8% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$2
Low
$2
Avg Target
$2
High
Based on 1 analyst since Aug 13, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 1Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$1.50
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-18 H.C. Wainwright Swayampakula Ramakanth Initiated $2 — -48.9% $2.94

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
Oct 02, 2026
DCF
4
ROE
1
ROA
1
D/E
2
P/E
1
P/B
5
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AEMD receives an overall rating of B-. Strongest factors: DCF (4/5), P/B (5/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-09-18 B B-
2026-08-14 B- B
2026-06-15 C B-
2026-06-11 C+ C
2026-06-11 C C+
2026-06-10 B- C
2026-02-26 C+ B-
2026-02-20 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
0
Earnings Quality
66
Growth
—
Value
30
Momentum
—
Safety
0
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-35.95
Distress Zone
Piotroski F-Score
4/9
✗ ✗ ✓ ✓ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
4.43
Bankruptcy prob: 98.8%
High Risk
Credit Rating
B+
Score: 33.7/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.98x
Accruals: -2.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AEMD scores -35.95, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AEMD scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AEMD's implied 98.8% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AEMD receives an estimated rating of B+ (score: 33.7/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.55x
PEG
-0.00x
P/S
0.00x
P/B
0.48x
P/FCF
-1.97x
P/OCF
—
EV/EBITDA
-1.37x
EV/Revenue
—
EV/EBIT
-1.27x
EV/FCF
-1.30x
Earnings Yield
-51.80%
FCF Yield
-50.72%
Shareholder Yield
0.04%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. AEMD currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.994
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.368
Assets / Equity
=
ROE
-142.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AEMD's ROE of -142.9% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.45
Median 1Y
$0.66
5th Pctile
$0.06
95th Pctile
$7.59
Ann. Volatility
154.8%
Analyst Target
$1.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
James B. Frakes
Chief Executive Officer and Chief Financial Officer
$500,000 $— $826,922
Steven P. LaRosa,
M.D. Chief Medical Officer
$473,000 $— $593,480
Guy F. Cipriani
Former Senior Vice President, Chief Operating Officer
$— $— $211,250

CEO Pay Ratio

1:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $826,922
Avg Employee Cost (SGA/emp): $810,403
Employees: 9

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
9
0.0% YoY
Revenue / Employee
—
Profit / Employee
$-794,608
NI: $-7,151,469
SGA / Employee
$810,403
Avg labor cost proxy
R&D / Employee
$212,444
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
ROE -42.7% -48.0% -55.1% -78.4% -56.2% -60.7% -70.3% -74.7% -88.1% -77.1% -98.4% -1.2% -1.1% -1.4% -1.6% -2.5% -2.1% -1.9% -2.1% -1.4% -1.43%
ROA -40.5% -45.3% -51.4% -69.2% -52.2% -55.5% -62.6% -65.2% -75.3% -64.9% -78.6% -94.8% -84.5% -1.0% -1.1% -1.7% -1.5% -1.4% -1.6% -1.0% -1.04%
ROIC 24.1% 37.4% -10.9% -10.4% -10.5% -6.4% -9.9% -5.4% -7.2% -7.7% -15.4% -7.9% -18.3% 220.3% -33.2% -27.1% -19.5% -14.5% -33.4% -29.3% -29.32%
ROCE -34.7% -38.5% -42.7% -59.2% -72.5% -61.5% -72.2% -74.4% -88.7% -1.1% -1.4% -2.0% -1.3% -1.8% -2.3% -2.5% -3.5% -1.9% -1.7% -1.5% -1.47%
Gross Margin 1.0% 1.0% 1.0% 1.0% — — — 1.0% — — — — — — — — — — — — —
Operating Margin -15.9% -15.2% -147.7% -288.6% — — — -4.3% — — — — — — — — — — — — —
Net Margin -15.9% -15.2% -147.6% -288.6% — — — -4.3% — — — — — — — — — — — — —
EBITDA Margin -15.8% -14.7% -146.7% -286.7% — — — -4.2% — — — — — — — — — — — — —
FCF Margin -9.9% -9.2% -28.7% -34.4% -66.4% -412.6% -899.8% -19.9% -19.8% -18.3% -18.8% — — — — — — — — — —
OCF Margin -9.8% -9.1% -28.2% -33.2% -64.3% -377.9% -812.6% -18.3% -17.9% -17.6% -18.3% — — — — — — — — — —
ROE 3Y Avg snapshot only -2.06%
ROE 5Y Avg snapshot only -1.52%
ROA 3Y Avg snapshot only -1.48%
ROIC 3Y Avg snapshot only -18.60%
ROIC Economic snapshot only -1.10%
Cash ROA snapshot only -1.11%
Cash ROIC snapshot only -35.61%
CROIC snapshot only -35.63%
Valuation
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
P/E Ratio -294.50 -269.68 -128.82 -86.34 -61.82 -37.09 -18.94 -29.16 -28.21 -19.29 -18.00 -14.48 -3.53 -3.37 -7.33 -1.67 -0.99 -1.32 -0.99 -1.93 -0.551
P/S Ratio 3191.81 2574.35 3634.08 3057.33 4278.40 15977.90 19275.48 610.94 609.44 390.70 383.96 — — — — — — — — — 0.000
P/B Ratio 101.51 103.14 55.35 52.49 46.07 24.31 14.63 23.29 26.70 21.74 28.97 30.65 4.66 6.31 16.17 4.36 3.64 2.59 1.70 2.83 0.477
P/FCF -323.08 -279.50 -126.62 -88.90 -64.40 -38.72 -21.42 -30.64 -30.72 -21.40 -20.48 -17.03 -4.32 -4.26 -8.20 -2.92 -1.64 -2.11 -1.65 -1.97 -1.972
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -292.85 -270.04 -128.06 -85.75 -61.32 -36.43 -18.17 -28.95 -27.95 -18.60 -18.73 -14.03 -2.82 -2.84 -6.37 -1.32 -0.76 -0.88 -0.44 -1.37 -1.370
EV/Revenue 3160.01 2549.19 3570.47 3001.77 4190.74 15373.29 18038.37 587.74 588.97 374.85 371.84 — — — — — — — — — —
EV/EBIT -291.39 -266.89 -126.49 -84.74 -60.54 -36.07 -17.91 -28.36 -27.27 -18.07 -18.16 -13.63 -2.74 -2.76 -6.17 -1.29 -0.74 -0.84 -0.42 -1.27 -1.267
EV/FCF -319.86 -276.77 -124.40 -87.29 -63.08 -37.26 -20.05 -29.48 -29.69 -20.53 -19.83 -16.59 -3.44 -3.58 -7.72 -2.29 -1.23 -1.35 -0.70 -1.30 -1.302
Earnings Yield -0.3% -0.4% -0.8% -1.2% -1.6% -2.7% -5.3% -3.4% -3.5% -5.2% -5.6% -6.9% -28.3% -29.7% -13.6% -59.9% -1.0% -75.6% -1.0% -51.8% -51.80%
FCF Yield -0.3% -0.4% -0.8% -1.1% -1.6% -2.6% -4.7% -3.3% -3.3% -4.7% -4.9% -5.9% -23.2% -23.5% -12.2% -34.2% -61.1% -47.4% -60.7% -50.7% -50.72%
Price/Tangible Book snapshot only 2.826
Shareholder Yield snapshot only 0.04%
Leverage & Solvency
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Current Ratio 22.58 24.19 19.83 9.95 9.66 9.76 7.46 10.03 7.31 6.13 3.93 3.40 4.49 3.06 2.80 3.13 2.49 4.45 5.68 3.85 3.849
Quick Ratio 22.58 24.19 19.83 9.95 9.66 9.76 7.46 10.03 7.31 6.13 3.93 3.40 4.49 3.06 2.80 3.13 2.49 4.45 5.68 3.85 3.849
Debt/Equity 0.00 0.00 0.02 0.04 0.05 0.07 0.07 0.08 0.09 0.10 0.13 0.16 0.10 0.13 0.17 0.13 0.20 0.09 0.06 0.07 0.069
Net Debt/Equity -1.01 -1.01 -0.97 -0.95 -0.94 -0.92 -0.94 -0.88 -0.90 -0.88 -0.91 -0.78 -0.94 -1.01 -0.95 -0.95 -0.90 -0.93 -0.97 -0.96 -0.960
Debt/Assets 0.00 0.00 0.02 0.04 0.04 0.06 0.06 0.07 0.07 0.08 0.10 0.11 0.08 0.09 0.11 0.09 0.13 0.07 0.05 0.05 0.053
Debt/EBITDA -0.00 -0.00 -0.04 -0.07 -0.06 -0.10 -0.10 -0.10 -0.09 -0.09 -0.09 -0.08 -0.08 -0.07 -0.07 -0.05 -0.06 -0.05 -0.04 -0.05 -0.051
Net Debt/EBITDA 2.95 2.67 2.28 1.59 1.28 1.43 1.25 1.14 0.97 0.79 0.61 0.37 0.71 0.54 0.40 0.37 0.25 0.49 0.60 0.70 0.705
Interest Coverage -8780.75 -9023.75 -50855.78 -83367.09 — — — — — — — — — — — -1343.61 -1258.63 -1118.66 -1138.79 -500.73 -500.730
Equity Multiplier 1.04 1.04 1.06 1.13 1.14 1.16 1.20 1.16 1.21 1.24 1.37 1.43 1.31 1.47 1.51 1.44 1.55 1.27 1.20 1.30 1.296
Cash Ratio snapshot only 3.474
Debt Service Coverage snapshot only -462.954
Cash to Debt snapshot only 14.928
FCF to Debt snapshot only -20.795
Defensive Interval snapshot only 271.8 days
Efficiency & Turnover
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Asset Turnover 0.04 0.05 0.02 0.02 0.01 0.00 0.00 0.03 0.03 0.03 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 4.67 7.57 2.55 2.12 1.31 0.24 0.20 8.98 10.00 10.00 — — — — — — — 0.00 — — —
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.29 0.52 1.01 1.18 1.181
DSO 78 48 143 172 278 1490 1836 41 36 36 0 — — — — — — — — — —
DIO — — — — — — — — — — — — — — — 0 0 0 0 0 0.0 days
DPO — — — — — — — — — — — — — — — 2856 1253 696 360 309 308.9 days
Cash Conversion Cycle — — — — — — — — — — — — — — — — — — — — —
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 27.6% 48.8% -62.1% -55.4% -79.5% -96.7% -95.8% 95.2% 2.5% 18.0% 42.8% -1.0% -1.0% -1.0% -1.0% — — — — — —
Net Income -49.9% -52.4% -20.1% -32.1% -30.9% -47.8% -50.1% -15.5% -10.5% 10.7% 8.2% -1.5% 7.3% 3.1% 22.0% -9.7% -9.4% 0.1% -20.5% 46.6% 46.58%
EPS -12.6% -19.5% 5.7% -25.0% -8.4% -9.6% -0.7% 22.4% 29.6% 25.4% 16.3% 11.5% -10.6% -18.1% 3.6% -84.8% -7.3% 48.8% 70.2% 93.4% 93.39%
FCF -49.7% -61.6% -45.8% -48.2% -37.9% -46.7% -30.4% -13.2% -5.7% 16.0% 8.8% 9.3% 17.3% 14.9% 20.6% 26.3% 19.1% 20.9% 19.0% 8.4% 8.42%
EBITDA -48.5% -50.1% -19.2% -31.2% -29.9% -46.4% -48.1% -13.2% -9.2% 9.3% 12.4% -5.3% 5.0% 3.0% 9.2% -7.9% -7.1% 3.5% -5.9% 49.8% 49.76%
Op. Income -48.6% -50.9% -20.1% -32.1% -30.9% -46.2% -48.4% -14.2% -10.4% 7.6% 4.4% -6.2% 4.5% 2.8% 22.2% 26.1% 28.2% 38.5% 25.0% 21.9% 21.92%
OCF Growth snapshot only 8.46%
Asset Growth snapshot only -13.95%
Equity Growth snapshot only -4.63%
Debt Growth snapshot only -48.18%
Shares Change snapshot only 7.08%
Growth (CAGR)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 3Y 38.3% 45.6% 12.0% 8.6% 13.8% -35.0% -70.7% -4.1% -2.5% -2.5% -11.6% — — — — — — — — — —
Revenue 5Y 2.5% 0.6% -12.0% -5.6% -16.0% — -29.4% 30.9% 13.9% 13.9% 20.7% — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — -2.5% -2.5% -11.6% — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 58.8% 65.4% 64.2% 67.6% 80.1% 1.6% 64.2% 19.0% -1.3% -5.2% -6.3% -8.2% -23.9% -28.2% -33.2% -27.6% -32.3% -31.8% -27.0% -28.7% -28.75%
Assets 5Y 77.7% 90.5% 94.4% 62.3% 1.0% 82.3% 29.2% 19.0% 19.6% 19.5% 16.1% 14.9% 31.2% 47.2% 6.9% -6.7% -20.2% -13.4% -8.7% -9.9% -9.91%
Equity 3Y 68.3% 77.4% 84.6% 91.9% 1.4% 4.1% 63.8% 17.0% -5.1% -9.0% -13.0% -15.1% -29.5% -36.1% -40.6% -33.1% -39.0% -33.9% -27.0% -31.3% -31.29%
Book Value 3Y -24.0% -24.5% -21.1% -16.7% 2.6% 1.0% -17.9% -17.0% -30.3% -28.5% -31.9% -30.3% -39.6% -41.8% -45.9% -33.4% -44.7% -46.8% -52.3% -61.1% -61.07%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue Stability 0.02 0.00 0.00 0.03 0.01 0.14 0.00 0.21 0.02 0.00 0.00 0.04 0.01 0.01 0.24 0.67 0.56 0.44 0.54 0.78 0.780
Earnings Stability 0.25 0.21 0.48 0.49 0.54 0.66 0.76 0.90 0.88 0.78 0.86 0.94 0.79 0.62 0.48 0.94 0.78 0.47 0.26 0.01 0.013
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 1.00 1.00 — —
Rev. Growth Consistency 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.50 1.00 1.00 0.00 0.00 1.00 0.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.80 0.50 0.92 0.87 0.88 0.81 0.50 0.94 0.96 0.96 0.97 0.99 0.97 0.99 0.91 0.96 0.96 1.00 0.92 0.81 0.814
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 2.95 24.72 0.68 0.15 -0.39 -0.25 -0.24 -0.08 -0.40 -0.61 -1.01 -1.41 -0.47 -0.98 -1.01 -1.16 -2.54 -0.46 0.19 0.90 0.902
Gross Margin Trend 4651.68 4651.68 977.51 466.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 — — — — — — — — — —
FCF Margin Trend 15.80 17.42 -20.08 -25.10 -57.29 -403.79 -881.71 2.44 18.32 192.66 445.50 — — — — — — — — — —
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
OCF/Net Income 0.90 0.95 1.00 0.94 0.93 0.88 0.80 0.87 0.83 0.87 0.86 0.83 0.82 0.79 0.89 0.57 0.61 0.63 0.60 0.98 0.979
FCF/OCF 1.01 1.01 1.02 1.04 1.03 1.09 1.11 1.09 1.11 1.04 1.02 1.02 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.001
FCF/Net Income snapshot only 0.979
CapEx/Revenue 10.2% 12.5% 45.1% 1.2% 2.2% 34.8% 87.2% 1.6% 2.0% 69.6% 44.8% — — — — — — — — — —
CapEx/Depreciation snapshot only 0.004
Accruals Ratio -0.04 -0.02 0.00 -0.04 -0.04 -0.07 -0.13 -0.08 -0.13 -0.09 -0.11 -0.16 -0.15 -0.22 -0.12 -0.74 -0.59 -0.52 -0.63 -0.02 -0.022
Sloan Accruals snapshot only -0.069
Cash Flow Adequacy snapshot only -3402.232
Dividends & Buybacks
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0% 0.04%
Net Buyback Yield -0.7% -0.7% -1.5% -1.9% -0.1% -1.8% -3.5% -2.5% -2.7% -0.5% -0.6% -0.7% -13.8% -14.8% -7.7% -15.8% -14.7% -12.7% -51.8% -49.9% -49.95%
Total Shareholder Return -0.7% -0.7% -1.5% -1.9% -0.1% -1.8% -3.5% -2.5% -2.7% -0.5% -0.6% -0.7% -13.8% -14.8% -7.7% -15.8% -14.7% -12.7% -51.8% -49.9% -49.95%
DuPont Factors
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.00 0.98 1.04 0.97 0.97 0.97 0.89 0.99 0.99 1.00 1.00 0.99 0.994
EBIT Margin -10.84 -9.55 -28.23 -35.43 -69.23 -426.19 -1006.93 -20.72 -21.60 -20.74 -20.47 — — — — — — — — — —
Asset Turnover 0.04 0.05 0.02 0.02 0.01 0.00 0.00 0.03 0.03 0.03 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.05 1.06 1.07 1.13 1.08 1.09 1.12 1.15 1.17 1.19 1.25 1.24 1.25 1.33 1.42 1.43 1.38 1.37 1.32 1.37 1.368
Per Share
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
EPS (Diluted TTM) $-66.83 $-57.25 $-57.75 $-67.64 $-72.46 $-62.77 $-58.16 $-52.46 $-51.03 $-46.83 $-48.67 $-46.42 $-56.45 $-55.33 $-46.93 $-85.77 $-60.58 $-28.32 $-14.00 $-5.67 $-5.67
Book Value/Share $193.87 $149.70 $134.42 $111.25 $97.24 $95.75 $75.29 $65.70 $53.92 $41.54 $30.24 $21.93 $42.77 $29.55 $21.28 $32.82 $16.49 $14.45 $8.16 $3.88 $13.52
Tangible Book/Share $193.43 $149.68 $134.40 $111.24 $97.23 $95.74 $75.28 $65.69 $53.92 $41.54 $30.23 $21.92 $42.77 $29.55 $21.27 $32.82 $16.49 $14.45 $8.16 $3.88 $3.88
Revenue/Share $6.17 $6.00 $2.05 $1.91 $1.05 $0.15 $0.06 $2.50 $2.36 $2.31 $2.28 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-60.91 $-55.24 $-58.76 $-65.69 $-69.57 $-60.12 $-51.42 $-49.93 $-46.86 $-42.21 $-42.78 $-39.47 $-46.22 $-43.79 $-41.95 $-48.98 $-36.66 $-17.75 $-8.41 $-5.55 $-4967.38
OCF/Share $-60.29 $-54.49 $-57.84 $-63.42 $-67.30 $-55.06 $-46.44 $-45.81 $-42.20 $-40.60 $-41.76 $-38.52 $-46.12 $-43.72 $-41.92 $-48.98 $-36.66 $-17.75 $-8.41 $-5.55 $-4943.59
Cash/Share $196.19 $150.91 $132.43 $110.86 $96.33 $94.48 $76.25 $63.38 $53.06 $40.97 $31.67 $20.69 $44.54 $33.67 $23.69 $35.24 $18.13 $14.73 $8.45 $3.99 $12.82
EBITDA/Share $-66.53 $-56.62 $-57.08 $-66.86 $-71.57 $-61.49 $-56.73 $-50.84 $-49.78 $-46.59 $-45.30 $-46.68 $-56.43 $-55.12 $-50.84 $-84.84 $-59.31 $-27.25 $-13.32 $-5.28 $-5.28
Debt/Share $0.13 $0.00 $2.21 $4.74 $4.55 $6.38 $5.55 $5.27 $4.71 $4.34 $4.01 $3.58 $4.27 $3.92 $3.56 $4.16 $3.31 $1.25 $0.51 $0.27 $0.27
Net Debt/Share $-196.06 $-150.91 $-130.22 $-106.12 $-91.79 $-88.09 $-70.70 $-58.11 $-48.35 $-36.63 $-27.66 $-17.12 $-40.27 $-29.75 $-20.13 $-31.08 $-14.83 $-13.48 $-7.94 $-3.72 $-3.72
Per Employee
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Employee Count snapshot only 9
Revenue/Employee snapshot only $0.00
Income/Employee snapshot only $-794607.56
EBITDA/Employee snapshot only $-739286.44
FCF/Employee snapshot only $-778011.33
Assets/Employee snapshot only $703678.56
Market Cap/Employee snapshot only $1534034.17
Academic Models
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -35.952
Altman Z-Prime snapshot only -83.483
Piotroski F-Score 3 4 2 3 1 1 1 3 2 2 2 1 2 2 3 3 1 3 3 4 4
Beneish M-Score — — 29.27 -2.64 — — — 34.53 — — — — — — — — — — — — —
Ohlson O-Score snapshot only 4.427
ROIC (Greenblatt) snapshot only -1.50%
Net-Net WC snapshot only $3.27
EVA snapshot only $-5781622.48
Credit
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Credit Rating snapshot only B+
Credit Score 59.74 67.07 61.07 62.18 74.83 75.07 76.13 74.54 75.05 74.47 74.73 74.30 44.48 43.78 43.35 33.28 30.81 33.48 33.79 33.75 33.748
Credit Grade snapshot only 14
Credit Trend snapshot only 0.471
Implied Spread (bps) snapshot only 650.000
Industry Credit Rank snapshot only 30
Sector Credit Rank snapshot only 23

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms